Blair SN, Church TS. The fitness, obesity, and health equation: is physical activity the common denominator? JAMA 2004; 292: 1232–1234.
Egan B, Zierath JR. Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metab 2013; 17: 162–184.
Holloszy JO. Regulation by exercise of skeletal muscle content of mitochondria and GLUT4. J Physiol Pharmacol 2008; 59 (Suppl 7): 5–18.
Hood DA. Mechanisms of exercise-induced mitochondrial biogenesis in skeletal muscle. Appl Physiol Nutr Metab 2009; 34: 465–472.
Rockl KS, Witczak CA, Goodyear LJ. Signaling mechanisms in skeletal muscle: acute responses and chronic adaptations to exercise. IUBMB Life 2008; 60: 145–153.
Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol 2012; 8: 457–465.
Febbraio MA. Signaling pathways for IL-6 within skeletal muscle. Exerc Immunol Rev 2003; 9: 34–39.
Carey AL, Steinberg GR, Macaulay SL, Thomas WG, Holmes AG, Ramm G et al. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes 2006; 55: 2688–2697.
McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997; 387: 83–90.
Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012; 481: 463–468.
Izumiya Y, Bina HA, Ouchi N, Akasaki Y, Kharitonenkov A, Walsh K. FGF21 is an Akt-regulated myokine. FEBS Lett 2008; 582: 3805–3810.
Hondares E, Rosell M, Gonzalez FJ, Giralt M, Iglesias R, Villarroya F. Hepatic FGF21 expression is induced at birth via PPARalpha in response to milk intake and contributes to thermogenic activation of neonatal brown fat. Cell Metab 2010; 11: 206–212.
Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ et al. FGF-21 as a novel metabolic regulator. J Clin Invest 2005; 115: 1627–1635.
Chavez AO, Molina-Carrion M, Abdul-Ghani MA, Folli F, Defronzo RA, Tripathy D. Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance. Diabetes Care 2009; 32: 1542–1546.
Cuevas-Ramos D, Almeda-Valdes P, Meza-Arana CE, Brito-Cordova G, Gomez-Perez FJ, Mehta R et al. Exercise increases serum fibroblast growth factor 21 (FGF21) levels. PLoS One 2012; 7: e38022.
Hittel DS, Axelson M, Sarna N, Shearer J, Huffman KM, Kraus WE. Myostatin decreases with aerobic exercise and associates with insulin resistance. Med Sci Sports Exerc 2010; 42: 2023–2029.
Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 2012; 61: 1725–1738.
Yang SJ, Hong HC, Choi HY, Yoo HJ, Cho GJ, Hwang TG et al. Effects of a three-month combined exercise programme on fibroblast growth factor 21 and fetuin-A levels and arterial stiffness in obese women. Clin Endocrinol (Oxf) 2011; 75: 464–469.
de Glisezinski I, Moro C, Pillard F, Marion-Latard F, Harant I, Meste M et al. Aerobic training improves exercise-induced lipolysis in SCAT and lipid utilization in overweight men. Am J Physiol Endocrinol Metab 2003; 285: E984–E990.
Marquez-Quinones A, Mutch DM, Debard C, Wang P, Combes M, Roussel B et al. Adipose tissue transcriptome reflects variations between subjects with continued weight loss and subjects regaining weight 6 mo after caloric restriction independent of energy intake. Am J Clin Nutr 2010; 92: 975–984.
Moro C, Galgani JE, Luu L, Pasarica M, Mairal A, Bajpeyi S et al. Influence of gender, obesity, and muscle lipase activity on intramyocellular lipids in sedentary individuals. J Clin Endocrinol Metab 2009; 94: 3440–3447.
Taniguchi A, Fukushima M, Nagasaka S, Matsumoto K, Tokuyama K, Doi K et al. Insulin sensitivity indexes from a single sample in nonobese Japanese type 2 diabetic patients: comparison with minimal model analysis. Diabetes Care 2002; 25: 626–640.
Pillard F, Van Wymelbeke V, Garrigue E, Moro C, Crampes F, Guilland JC et al. Lipid oxidation in overweight men after exercise and food intake. Metabolism 2010; 59: 267–274.
Larrouy D, Barbe P, Valle C, Dejean S, Pelloux V, Thalamas C et al. Gene expression profiling of human skeletal muscle in response to stabilized weight loss. Am J Clin Nutr 2008; 88: 125–132.
Viguerie N, Picard F, Hul G, Roussel B, Barbe P, Iacovoni JS et al. Multiple effects of a short-term dexamethasone treatment in human skeletal muscle and adipose tissue. Physiol Genomics 2012; 44: 141–151.
Badin PM, Louche K, Mairal A, Liebisch G, Schmitz G, Rustan AC et al. Altered skeletal muscle lipase expression and activity contribute to insulin resistance in humans. Diabetes 2011; 60: 1734–1742.
Castan-Laurell I, Dray C, Knauf C, Kunduzova O, Valet P. Apelin, a promising target for type 2 diabetes treatment? Trends Endocrinol Metab 2012; 23: 234–241.
Konopka AR, Douglass MD, Kaminsky LA, Jemiolo B, Trappe TA, Trappe S et al. Molecular adaptations to aerobic exercise training in skeletal muscle of older women. J Gerontol A Biol Sci Med Sci 2010; 65: 1201–1207.
Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab 2013; 98: E769–E778.
Timmons JA, Baar K, Davidsen PK, Atherton PJ. Is irisin a human exercise gene? Nature 2012; 488: E9–E10 discussion E10–11.
Lambert CP, Wright NR, Finck BN, Villareal DT. Exercise but not diet-induced weight loss decreases skeletal muscle inflammatory gene expression in frail obese elderly persons. J Appl Physiol 2008; 105: 473–478.
Krist J, Wieder K, Kloting N, Oberbach A, Kralisch S, Wiesner T et al. Effects of weight loss and exercise on apelin serum concentrations and adipose tissue expression in human obesity. Obes Facts 2013; 6: 57–69.
Kadoglou NP, Fotiadis G, Kapelouzou A, Kostakis A, Liapis CD, Vrabas IS. The differential anti-inflammatory effects of exercise modalities and their association with early carotid atherosclerosis progression in patients with Type 2 diabetes. Diabet Med 2013; 30: e41–e50.
Kadoglou NP, Vrabas IS, Kapelouzou A, Lampropoulos S, Sailer N, Kostakis A et al. The impact of aerobic exercise training on novel adipokines, apelin and ghrelin, in patients with type 2 diabetes. Med Sci Monit 2012; 18: CR290–CR295.
Yamamoto T, Habata Y, Matsumoto Y, Yasuhara Y, Hashimoto T, Hamajyo H et al. Apelin-transgenic mice exhibit a resistance against diet-induced obesity by increasing vascular mass and mitochondrial biogenesis in skeletal muscle. Biochim Biophys Acta 2011; 1810: 853–862.
Akerstrom T, Steensberg A, Keller P, Keller C, Penkowa M, Pedersen BK. Exercise induces interleukin-8 expression in human skeletal muscle. J Physiol 2005; 563: 507–516.
Kotnik P, Fischer-Posovszky P, Wabitsch M. Eur J Endocrinol 2011; 165: 703–711.
Dray C, Knauf C, Daviaud D, Waget A, Boucher J, Buleon M et al. Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab 2008; 8: 437–445.
Sparks LM, Moro C, Ukropcova B, Bajpeyi S, Civitarese AE, Hulver MW et al. Remodeling lipid metabolism and improving insulin responsiveness in human primary myotubes. PLoS One 2011; 6: e21068.
Buford TW, Cooke MB, Willoughby DS. Resistance exercise-induced changes of inflammatory gene expression within human skeletal muscle. Eur J Appl Physiol 2009; 107: 463–471.
Barnes G, Japp AG, Newby DE. Translational promise of the apelin-APJ system. Heart 2010; 96: 1011–1016.
Mesmin C, Dubois M, Becher F, Fenaille F, Ezan E. Liquid chromatography/tandem mass spectrometry assay for the absolute quantification of the expected circulating apelin peptides in human plasma. Rapid Commun Mass Spectrom 2010; 24: 2875–2884.
Yue P, Jin H, Aillaud M, Deng AC, Azuma J, Asagami T et al. Apelin is necessary for the maintenance of insulin sensitivity. Am J Physiol Endocrinol Metab 2010; 298: E59–E67.